Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2023	May 01, 2022
Cash flows from operating activities:
Net (loss) income	$ (29,417)	$ 38,048
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:
Depreciation and amortization	24,523	7,668
Amortization of right-of-use assets	1,635	1,140
Investment impairments and credit loss reserves, net	33	24
Accretion of deferred financing costs and debt discount	1,414	121
Deferred income taxes	(3,337)	1,747
Share-based compensation	8,404	10,893
Loss on disposition of business operations and assets	19	8
Equity method loss (income)	7	(24)
Corporate-owned life insurance, net	1,445	(47)
Changes in assets and liabilities:
Accounts receivable, net	16,449	5,147
Inventories	(5,700)	712
Other assets	(14,430)	3,017
Accounts payable	(17,644)	(126)
Accrued liabilities	(71,809)	(16,808)
Other liabilities	(1,579)	(1,469)
Net cash (used in) provided by operating activities	(89,987)	50,051
Cash flows from investing activities:
Purchase of property, plant and equipment	(13,977)	(8,315)
Purchase of investments	(430)	(2,000)
Proceeds from corporate-owned life insurance	0	2,676
Premiums paid for corporate-owned life insurance	0	(2,676)
Net cash used in investing activities	(14,407)	(10,315)
Cash flows from financing activities:
Proceeds from revolving line of credit	40,000	10,000
Deferred financing costs	(4,667)	0
Payments for employee share-based compensation payroll taxes	(1,605)	(4,570)
Proceeds from exercise of stock options	0	417
Repurchase of common stock	0	(50,000)
Net cash provided by (used in) financing activities	33,728	(44,153)
Effect of foreign exchange rate changes on cash and cash equivalents	(646)	0
Net decrease in cash and cash equivalents	(71,312)	(4,417)
Cash and cash equivalents at beginning of period	235,510	279,601
Cash and cash equivalents at end of period	164,198	275,184
Supplemental disclosure of cash flow information:
Interest paid	17,117	987
Income taxes paid	8,662	3,347
Non-cash investing and financing activities:
Accounts payable related to capital expenditures	$ 3,664	$ 3,808